Pathogenesis
of the connection of HIV-infection and cancer is a problem for medical
professionals and presents an interesting area for research. The aim of the
study was to investigate the level of cancer biomarkers in HIV-infected
patients with a background of narcotic drugs use, via parenteral
administration, and in HIV-infected patients without a similar background.
Akhmaltdinova,
L.L., Azizov, I. S., Tyukhtina, Z. P., Serdyuk, L. I., Kozachenko, N.V., Sandle,
T., Moraru, D. and Chesca, A. (2020) Cancer biomarkers in HIV-infection
patients with and without drug addiction, Acta Medica Mediterranea, 36:
1129-1132
The
research revealed the increased levels of sHER-2, sEGRf, sIL-6RA, sVEGfr2,
PECAM1, sTIE2 in all HIV-infected patients. SCF and FGF markers were increased
only in injecting drug users (HIV+/HIV-). The drug addicts with HIV had the
increased level of inflammatory markers sIL-6RA, PECAM 1, osteopantin and the
level of HER-2.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a comment
Pharmaceutical Microbiology Resources